Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation

References

• Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2003; 83: 113–118
   Web of Science ®Google Scholar
• Clarkson T B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002; 132: 566–569S
   PubMed Web of Science ®Google Scholar
• Murkies A L, Wilcox G, Davis S R. Phytoestrogens. J Clin Endocrinol Metab 1998; 83: 297–303
   PubMed Web of Science ®Google Scholar
• Erdman J W. Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA. Circulation 2000; 102: 2555–2559
   PubMed Web of Science ®Google Scholar
• Sacks F M, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M, for the American Heart Association Nutrition Committee. Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee. Circulation 2006; 113: 1034–1044
   PubMed Web of Science ®Google Scholar
• Dewell A, Hollenbeck P L, Hollenbeck C B. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 2006; 91: 772–780
   PubMed Web of Science ®Google Scholar
• Gu L, House S E, Prior R L, et al. Metabolic phenotypes of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 2006; 136: 1215–1221
   PubMed Web of Science ®Google Scholar
• Setchell K DR, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132: 3577–3584
   PubMed Web of Science ®Google Scholar
• Atkinson C, Frankenfeld C L, Lampe J W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005; 230: 155–170
   PubMed Web of Science ®Google Scholar
• Duncan A M, Merz-Demlow B E, Xu X, Phipps W R, Kurzer M S. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 581–586
   PubMed Web of Science ®Google Scholar
• Frankenfeld C L, McTiernan A, Tworoger S S, et al. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 2004; 88: 399–408
   PubMed Web of Science ®Google Scholar
• Atkinson C, Berman S, Thomas W, Lampe J. The in vitro metabolism of estrogens by human fecal bacteria: a comparison of equol-producers and non-producers. J Nutr 2007, in press
   Google Scholar
• Speroff L, Clarkson T B. Is tibolone a viable alternative to HT?. Contemporary Ob/Gyn 2003; 2–11
   Google Scholar
• Kenemans P, Speroff L, for the International Tibolone Consensus Group. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 2005; 51: 21–28
   PubMed Web of Science ®Google Scholar
• Vos R M, Krebbers S F, Verhoeven C H, Delbressine L P. The in vivo human metabolism of tibolone. Drug Metab Dispos 2002; 30: 106–112
   PubMed Web of Science ®Google Scholar
• Kshirsagar A V, Carpenter M, Bang H, Wyatt S B, Colindres R E. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119: 133–141
   PubMed Web of Science ®Google Scholar
• Törmälä R M, Nikander E, Tiitinen A, Väisänen-Tommiska M, Ylikorkala O, Mikkola T S. Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones. Menopause 2006; 13: 96–101
   PubMed Web of Science ®Google Scholar
• Verheul H A, Blok L J, Burger C W, Hanifi-Moghaddam P, Kloosterboer H J. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium and vagina of postmenopausal women treated for 21 days with tibolone, estradiol or estradiol plus medroxyprogesteroneacetate. Reprod Sci 2007; 14: 160–168
   PubMed Web of Science ®Google Scholar
• Mueck A O, Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas 2004; 49: 189–203
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Baldassari F, Arangino S, Alessandrini C, Volpe A. Administration of tibolone decreases 24 h heart rate but not blood pressure of post-menopausal women. Maturitas 2004; 48: 155–160
   PubMed Web of Science ®Google Scholar
• Setchell K D, Borriello S P, Hulme P, Kirk D N, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984; 40: 569–578
   PubMed Web of Science ®Google Scholar
• Setchell K D, Faughnan M S, Avades T, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 2003; 77: 411–419
   PubMed Web of Science ®Google Scholar
• Grace P B, Taylor J I, Low Y L, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004; 13: 698–708
   PubMed Web of Science ®Google Scholar
• Chin-Dusting J PF, Fisher L J, Lewis T V, Piekarska A, Nestel P J, Husband A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol 2001; 133: 595–605
   PubMed Web of Science ®Google Scholar
• Giménez I, Lou M, Vargas F, et al. Renal and vascular actions of equol in the rat. J Hypertension 1997; 15: 1303–1308
   PubMed Web of Science ®Google Scholar
• Setchell K DR, Clerici C, Lephart E D, et al. S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by the human bacterial flora. Am J Clin Nutr 2005; 81: 1072–1079
   PubMed Web of Science ®Google Scholar
• Kloosterboer J H. Tissue-selectivity: the mechanism of action of tibolone. Maturitas 2004; 48: S30–40
   PubMed Web of Science ®Google Scholar
• Harris R M, Wood D M, Bottomley L, et al. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 2004; 89: 1779–1787
   PubMed Web of Science ®Google Scholar
• Kreijkamp-Kaspers S, Kok L, Bots M L, Grobbee D E, Lampe J W, van der Schouw Y T. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005; 81: 189–195
   PubMed Web of Science ®Google Scholar
• Dalais F S, Ebeling P R, Kotsopoulos D, McGrath B P, Teede H J. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol 2003; 58: 704–709
   PubMed Web of Science ®Google Scholar
• Tham D M, Gardner C D, Haskell W L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 1998; 83: 2223–2235
   PubMed Web of Science ®Google Scholar
• Rivas M, Garay R P, Escanero J F, Cia P, Jr, Cia P, Alda J O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002; 132: 1900–1902
   PubMed Web of Science ®Google Scholar
• Kotsopoulos D, Dalais F S, Liang Y L, McGrath B P, Teede H J. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 3: 161–167
   PubMedGoogle Scholar
• Appel L J, Brands M W, Daniels S R, Karanja N, Elmer P J, Sacks F M, American Heart Association. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47: 296–308
   PubMed Web of Science ®Google Scholar
• Miller E R, 3rd, Jehn M L. New high blood pressure guidelines create new at-risk classification: changes in blood pressure classification by JNC 7. J Cardiovasc Nurs 2004; 19: 367–371
   PubMedGoogle Scholar